Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BigBear.ai heads into its October 27 earnings with one of the most heavily shorted books in the small-cap AI universe, a lending market that tightened sharply this week, and options traders more bullish than the fundamentals would suggest.
Short interest is the dominant story here. At 34.3% of the free float, short sellers control more than a third of tradeable shares. That figure has crept higher all month, up roughly 0.9% over the past week and 2.7% over the past month, with the official FINRA settlement date reading from September 30 putting covered shares at 140.9 million, implying 10.3 days to cover. The ORTEX short score of 78.1 places the stock in the 98th percentile for short pressure relative to the broader market. What makes the week's move notable is not the incremental rise in SI, but the sudden tightening of the lending pool. Availability dropped to 3.9% of shares already borrowed, down from around 13% just a week ago, meaning for every 26 shares currently lent out, fewer than one remains available to new shorts. The cost to borrow is modest at 1.54%, up 12% on the week but not at levels that would signal imminent squeeze pressure. The setup is a structurally crowded short with a rapidly shrinking borrow window.
Options positioning tells a contrasting story. Call demand is running well ahead of put demand, with the put/call ratio at 0.26, near the bottom of its 52-week range and more than a standard deviation below its 20-day average of 0.27. With the 52-week low on the PCR sitting at 0.26, options traders are about as bullishly positioned on BBAI as they have been all year. That divergence between the short book and the options market is the week's most interesting tension: one side is making a structural bet against recovery, the other is paying for upside into earnings.
The Street offers little conviction to either camp. The sole active analyst coverage comes from Cantor Fitzgerald, which maintains a Neutral rating with a $4.00 target (cut from $5.00 in late July), and HC Wainwright, which holds a Buy with a $6.00 target (cut from $8.00 in March). Both have been steadily lowering targets since mid-2025. At a current price of $2.39, the mean target of $4.00 implies significant paper upside, but the direction of travel from the analysts who cover it has been one of persistent disappointment. The bear case is concrete: Q3 2025 revenue came in at $33.1 million versus $41.5 million a year earlier, and the company slashed its full-year guidance from a $160 million to $180 million range down to $125 million to $140 million. The price-to-book multiple of 27.2x on a loss-making business with a deeply negative return on assets underlines why the short thesis commands such broad support.
On the ownership side, the most consequential registered holder, Michael R. Greene, filed a Schedule 13D and has since reduced his stake from a peak of 25.7% to just 0.2% as last disclosed in April 2025. That exit is material context for anyone assessing the cap table. BlackRock has been building, filing a 13G/A in July 2026 showing 8.2% of the class, up from 6.8%, while Vanguard Capital Management filed a fresh 13G in July at 5.2%. These are passive index-type positions, not activist conviction, but the passive bid provides a floor under the float. As always with 13D/G disclosures, these stakes are as-last-disclosed around the 5% threshold, and holders dropping below 5% may not file again. Insider activity from the past 90 days is exclusively tax-withholding transactions from the CEO, CFO and General Counsel, code-F filings with no open-market buying, which nets to zero discretionary signal.
Recent earnings reactions give the clearest read on event risk. The two most recent prints, August 4 and July 30 2026, both produced the same outcome: the stock rose roughly 6% to 8% on the day, then extended to gains of around 16% over the following five sessions. That pattern is striking for a name with a deteriorating fundamental backdrop, and it likely explains the bullish tilt in the options market. The ORTEX Wikipedia attention z-score sits at 2.3, above its own 90-day history, suggesting retail engagement with the name is elevated.
With 17 days to the October 27 print, the question framing itself is whether the pattern of short-term post-earnings bounces can repeat despite the guidance cuts, or whether tightening availability will become the story before the release date.
See the live data behind this article on ORTEX.
Open BBAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
